SEARCH

SEARCH BY CITATION

References

  • 1
    Kissebah, A. H., Vydelingum, N., Murray, R., et al (1982) Relation of body fat distribution to metabolic complications of obesity. J Clin Endocrinol Metab. 54: 254260.
  • 2
    Krotkiewski, M., Björntorp, P., Sjöström, L., Smith, U. (1983) Impact of obesity on metabolism in men and women. Importance of regional adipose tissue distribution. J Clin Invest. 72: 11501162.
  • 3
    Carr, D. B., Utzschneider, K. M., Hull, R. L., et al (2004) Intra-abdominal fat is a major determinant of the National Cholesterol Education Program Adult Treatment Panel III criteria for the metabolic syndrome. Diabetes 53: 20872094.
  • 4
    Cnop, M., Landchild, M. J., Vidal, J., et al (2002) The concurrent accumulation of intra-abdominal and subcutaneous fat explains the association between insulin resistance and plasma leptin concentrations: distinct metabolic effects of two fat compartments. Diabetes 51: 10051015.
  • 5
    Wagenknecht, L. E., Langefeld, C. D., Scherzinger, A. L., et al (2003) Insulin sensitivity, insulin secretion, and abdominal fat: the Insulin Resistance Atherosclerosis Study (IRAS) Family Study. Diabetes 52: 24902496.
  • 6
    Katsuki, A., Sumida, Y., Urakawa, H., et al (2003) Increased visceral fat and serum levels of triglyceride are associated with insulin resistance in Japanese metabolically obese, normal weight subjects with normal glucose tolerance. Diabetes Care 26: 23412344.
  • 7
    Nicklas, B. J., Penninx, B. W., Ryan, A. S., Berman, D. M., Lynch, N. A., Dennis, KE (2003) Visceral adipose tissue cutoffs associated with metabolic risk factors for coronary heart disease in women. Diabetes Care 26: 14131420.
  • 8
    Nieves, D. J., Cnop, M., Retzlaff, B., et al (2003) The atherogenic lipoprotein profile associated with obesity and insulin resistance is largely attributable to intra-abdominal fat. Diabetes 52: 172179.
  • 9
    Wajchenberg, BL (2000) Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome. Endocr Rev. 21: 697738.
  • 10
    Lonnqvist, F., Thome, A., Nilsell, K., Hoffstedt, J., Arner, P. (1995) A pathogenic role of visceral fat beta 3-adrenoceptors in obesity. J Clin Invest. 95: 11091116.
  • 11
    Nielsen, S., Guo, Z., Johnson, C. M., Hensrud, D. D., Jensen, MD (2004) Splanchnic lipolysis in human obesity. J Clin Invest. 113: 15821588.
  • 12
    van Harmelen, V., Dicker, A., Ryden, M., et al (2002) Increased lipolysis and decreased leptin production by human omental as compared with subcutaneous preadipocytes. Diabetes 51: 20292036.
  • 13
    Westerbacka, J., Corner, A., Tiikkainen, M., et al (2004) Women and men have similar amounts of liver and intra-abdominal fat, despite more subcutaneous fat in women: implications for sex differences in markers of cardiovascular risk. Diabetologia 47: 13601369.
  • 14
    Pietilainen, K. H., Rissanen, A., Kaprio, J., et al (2005) Acquired obesity is associated with increased liver fat, intra-abdominal fat, and insulin resistance in young adult monozygotic twins. Am J Physiol Endocrinol Metab. 288: E768E774.
  • 15
    Thamer, C., Machann, J., Haap, M., et al (2004) Intrahepatic lipids are predicted by visceral adipose tissue mass in healthy subjects. Diabetes Care 27: 27262729.
  • 16
    Kelley, D. E., McKolanis, T. M., Hegazi, R. A., Kuller, L. H., Kalhan, SC (2003) Fatty liver in type 2 diabetes mellitus: relation to regional adiposity, fatty acids, and insulin resistance. Am J Physiol Endocrinol Metab. 285: E906E916.
  • 17
    Kabir, M., Catalano, K. J., Ananthnarayan, S., et al (2005) Molecular evidence supporting the portal theory: a causative link between visceral adiposity and hepatic insulin resistance. Am J Physiol Endocrinol Metab. 288: E454E461.
  • 18
    Mittelman, S. D., Van Citters, G. W., Kirkman, E. L., Bergman, RN (2002) Extreme insulin resistance of the central adipose depot in vivo. Diabetes 51: 755761.
  • 19
    Tiikkainen, M., Bergholm, R., Vehkavaara, S., et al (2003) Effects of identical weight loss on body composition and features of insulin resistance in obese women with high and low liver fat content. Diabetes 52: 701707.
  • 20
    Goodpaster, B. H., Kelley, D. E., Wing, R. R., Meier, A., Thaete, FL (1999) Effects of weight loss on regional fat distribution and insulin sensitivity in obesity. Diabetes 48: 839847.
  • 21
    Ranlov, I., Hardt, F. (1990) Regression of liver steatosis following gastroplasty or gastric bypass for morbid obesity. Digestion 47: 208214.
  • 22
    Fujioka, S., Matsuzawa, Y., Tokunaga, K., et al (1991) Improvement of glucose and lipid metabolism associated with selective reduction of intra-abdominal visceral fat in premenopausal women with visceral fat obesity. Int J Obes Relat Metab Disord. 15: 853859.
  • 23
    Barzilai, N., She, L., Liu, B. Q., et al (1999) Surgical removal of visceral fat reverses hepatic insulin resistance. Diabetes 48: 9498.
  • 24
    Gabriely, I., Ma, X. H., Yang, X. M., et al (2002) Removal of visceral fat prevents insulin resistance and glucose intolerance of aging: an adipokine-mediated process? Diabetes 51: 29512958.
  • 25
    Hayashi, T., Boyko, E. J., Leonetti, D. L., et al (2003) Visceral adiposity and the risk of impaired glucose tolerance: a prospective study among Japanese Americans. Diabetes Care 26: 650655.
  • 26
    Ohlson, L. O., Larsson, B., Svardsudd, K., et al (1985) The influence of body fat distribution on the incidence of diabetes mellitus. 13.5 years of follow-up of the participants in the study of men born in 1913. Diabetes 34: 10551058.
  • 27
    Tuomilehto, J., Lindstrom, J., Eriksson, J. G., et al (2001) Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med. 344: 13431350.
  • 28
    Roecker, K., Schotte, O., Niess, A. M., Horstmann, T., Dickhuth, HH (1998) Predicting competition performance in long-distance running by means of a treadmill test. Med Sci Sports Exerc. 30: 15521557.
  • 29
    Matsuda, M., DeFronzo, RA (1999) Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 22: 14621470.
  • 30
    Seppala-Lindroos, A., Vehkavaara, S., Hakkinen, A. M., et al (2002) Fat accumulation in the liver is associated with defects in insulin suppression of glucose production and serum free fatty acids independent of obesity in normal men. J Clin Endocrinol Metab. 87: 30233028.
  • 31
    Garg, A., Misra, A. (2002) Hepatic steatosis, insulin resistance, and adipose tissue disorders. J Clin Endocrinol Metab. 87: 30193022.
  • 32
    Staiger, H., Tschritter, O., Machann, J., et al (2003) Relationship of serum adiponectin and leptin concentrations with body fat distribution in humans. Obes Res. 11: 368372.
  • 33
    Stefan, N., Hennige, A. M., Staiger, H., et al (2006) Alpha2-Heremans-Schmid glycoprotein/fetuin-A is associated with insulin resistance and fat accumulation in the liver in humans. Diabetes Care 29: 853857.
  • 34
    Knowler, W. C., Barrett-Connor, E., Fowler, S. E., et al (2002) Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 346: 393403.
  • 35
    Stefan, N., Machicao, F., Staiger, H., et al (2005) Polymorphisms in the gene encoding adiponectin receptor 1 are associated with insulin resistance and high liver fat. Diabetologia 48: 22822291.
  • 36
    Stefan, N., Schafer, S., Machicao, F., et al (2005) Liver fat and insulin resistance are independently associated with the −514C>T polymorphism of the hepatic lipase gene. J Clin Endocrinol Metab. 90: 42384243.